JANUVIA
MERCK CANADA INC
Quick answers
Is there a shortage of JANUVIA in Canada?
No. There is no current shortage of JANUVIA 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
M-SITAGLIPTIN
MANTRA PHARMA INC
Other Products
JANUVIA
MERCK CANADA INC
APO-SITAGLIPTIN
APOTEX INC
SANDOZ SITAGLIPTIN
SANDOZ CANADA INCORPORATED
NAT-SITAGLIPTIN
NATCO PHARMA (CANADA) INC
PRO-SITAGLIPTIN
PRO DOC LIMITEE
DIN
02388847
Strength
50MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)
See all SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
20MG · DIN 02483548
10MG · DIN 02483513
15MG · DIN 02483521
100MG · DIN 02451816
50MG · DIN 02244265
70MG · DIN 02244266
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00688622
0.05% · DIN 00862975